Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk

Xavier Sendaydiego, Laura S. Gold, Maureen Dubreuil, James S. Andrews, Pankti Reid, David F. L. Liew, Radjiv Goulabchand, Abha Goyal Singh, Grant C. Hughes, Mathilde Pioro, Jeffrey A. Sparks, Jeffrey G. Jarvik, Siddharth Singh, Jean W. Liew, Namrata Singh

Open source

DOI: 10.1001/jamanetworkopen.2024.46336
Published: 2024-11-20
Container: JAMA Network Open
Publisher: American Medical Association (AMA)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamanetworkopen.2024.46336,
  title = {Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk},
  author = {Xavier Sendaydiego and Laura S. Gold and Maureen Dubreuil and James S. Andrews and Pankti Reid and David F. L. Liew and Radjiv Goulabchand and Abha Goyal Singh and Grant C. Hughes and Mathilde Pioro and Jeffrey A. Sparks and Jeffrey G. Jarvik and Siddharth Singh and Jean W. Liew and Namrata Singh},
  year = {2024},
  journal = {JAMA Network Open},
  doi = {10.1001/jamanetworkopen.2024.46336},
  url = {https://doi.org/10.1001/jamanetworkopen.2024.46336}
}

RIS

TY  - JOUR
TI  - Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk
AU  - Xavier Sendaydiego
AU  - Laura S. Gold
AU  - Maureen Dubreuil
AU  - James S. Andrews
AU  - Pankti Reid
AU  - David F. L. Liew
AU  - Radjiv Goulabchand
AU  - Abha Goyal Singh
AU  - Grant C. Hughes
AU  - Mathilde Pioro
AU  - Jeffrey A. Sparks
AU  - Jeffrey G. Jarvik
AU  - Siddharth Singh
AU  - Jean W. Liew
AU  - Namrata Singh
PY  - 2024
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2024.46336
UR  - https://doi.org/10.1001/jamanetworkopen.2024.46336
ER  -

APA

Sendaydiego, X., Gold, L. S., Dubreuil, M., Andrews, J. S., Reid, P., Liew, D. F. L., Goulabchand, R., Singh, A. G., Hughes, G. C., Pioro, M., Sparks, J. A., Jarvik, J. G., Singh, S., Liew, J. W., & Singh, N. (2024). Use of Biologic or Targeted Synthetic Disease-Modifying Antirheumatic Drugs and Cancer Risk. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.46336

Source records

crossref · retrieved 2026-09-27T03:08:20.109Z